Zobrazeno 1 - 10
of 220
pro vyhledávání: '"Christophe Deroose"'
Autor:
Tonci Ivanisevic, Mikhail Steklov, Benoit Lechat, Christopher Cawthorne, Willy Gsell, Greetje Vande Velde, Christophe Deroose, Koen Van Laere, Uwe Himmelreich, Raj N Sewduth, Anna A Sablina
Publikováno v:
Cancer Communications, Vol 43, Iss 12, Pp 1386-1390 (2023)
Externí odkaz:
https://doaj.org/article/afbe80ee102246ea8bc990602c51107f
Autor:
Natacha Breuls, Nefele Giarratana, Laura Yedigaryan, Gabriel Miró Garrido, Paolo Carai, Stephane Heymans, Adrian Ranga, Christophe Deroose, Maurilio Sampaolesi
Publikováno v:
Cell Death and Disease, Vol 12, Iss 7, Pp 1-13 (2021)
Abstract Muscular dystrophies are debilitating neuromuscular disorders for which no cure exists. As this disorder affects both cardiac and skeletal muscle, patients would benefit from a cellular therapy that can simultaneously regenerate both tissues
Externí odkaz:
https://doaj.org/article/c158e04ed7ab4505a6f9fb4c6d0db8c2
Autor:
Akila Weerasekera, Melissa Crabbé, Sandra O. Tomé, Willy Gsell, Diana Sima, Cindy Casteels, Tom Dresselaers, Christophe Deroose, Sabine Van Huffel, Dietmar Rudolf Thal, Philip Van Damme, Uwe Himmelreich
Publikováno v:
NeuroImage: Clinical, Vol 27, Iss , Pp 102327- (2020)
Currently TAR DNA binding protein 43 (TDP-43) pathology, underlying Amyotrophic Lateral Sclerosis (ALS), remains poorly understood which hinders both clinical diagnosis and drug discovery efforts. To better comprehend the disease pathophysiology, pos
Externí odkaz:
https://doaj.org/article/7b12c240f7ce41c28bf8719be368b7ab
Autor:
Charlotte Van de Kerkhove, Walter De Wever, Eric K. Verbeken, Christophe Deroose, Kris Nackaerts
Publikováno v:
Breathe, Vol 14, Iss 1, Pp 49-53 (2018)
Externí odkaz:
https://doaj.org/article/e3a9656e3a3a4a27b793329c82e22105
Autor:
Winnie Schats, Raphaëla Dresen, Regina G. H. Beets-Tan, Geert Maleux, V. O. Dezentjé, Christophe Deroose, T. R. Baetens, Hans Wildiers, B. J. de Wit-van der Veen, Elisabeth G. Klompenhouwer, F. M. Gómez Muñoz, B. M. Aarts, M. Lopez-Yurda
Publikováno v:
Cardiovascular and Interventional Radiology. 44(12):1868-1882
Purpose Performing a systematic review and meta-analysis to assess the evidence of intra-arterial therapies in liver metastatic breast cancer (LMBC) patients. Methods A systemic literature search was performed in PubMed, EMBASE, SCOPUS for studies re
Autor:
Michel Koole, Frederik Cleeren, Kim Serdons, Guy Bormans, Christophe Deroose, Térence Tshibangu, Jeroen Dekervel, Elin Pauwels, Koen Van Laere, Chris Verslype, Eric Van Cutsem
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 47:3033-3046
The widespread use of gallium-68-labelled somatostatin analogue (SSA) PET, the current standard for somatostatin receptor (SSTR) imaging, is limited by practical and economic challenges that could be overcome by a fluorine-18-labelled alternative, su
Autor:
Karin Haustermans, Kristof Baete, Kristiaan Nackaerts, Eric Van Cutsem, Chris Verslype, Elin Pauwels, Christophe Deroose, Hubert Vanbilloen, Felix M. Mottaghy, Michel Koole, Sofie Van Binnebeek, Vincent Vandecaveye, Paul Clement
Publikováno v:
Journal of Nuclear Medicine, 61(7), 1014-1020. Society of Nuclear Medicine and Molecular Imaging
We performed post hoc analyses on the utility of pretherapeutic and early interim 68Ga-DOTATOC PET tumor uptake and volumetric parameters and a recently proposed biomarker, the inflammation-based index (IBI), for peptide receptor radionuclide therapy
Autor:
Eric Van Cutsem, Olivier Gheysens, Karolien Goffin, Jeroen Dekervel, Sander Jentjens, Chris Verslype, Kristiaan Nackaerts, Koen Van Laere, Eva Medaer, Christophe Deroose, Paul Clement, Annouschka Laenen
Publikováno v:
Acta Oncologica. 59:644-651
Background: Peptide receptor radionuclide therapy (PRRT) is a validated treatment for somatostatin receptor overexpressing neuroendocrine tumors (NETs). The NETTER-1 trial demonstrated a pronounced...
Autor:
Frederik Cleeren, Elin Pauwels, Christophe Deroose, Térence Tshibangu, Kim Serdons, Christopher Cawthorne, Willy Gsell, Guy Bormans
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 5, Iss 1, Pp 1-23 (2020)
BackgroundGallium-68 labeled synthetic somatostatin analogs for PET/CT imaging are the current gold standard for somatostatin receptor imaging in neuroendocrine tumor patients. Despite good imaging properties, their use in clinical practice is hamper
Autor:
Frédéric Lecouvet, Laure Fournier, Nandita M. deSouza, Caroline Caramella, Joost J.C. Verhoeff, Christophe Deroose, Wolfgang G. Kunz, Bertrand Tombal, Laurence Collette, Marion Smits, Daniela E. Oprea-Lager, Lioe-Fee de Geus-Oei, Luc Bidaut, Egesta Lopci
Publikováno v:
Deroose, C M, Lecouvet, F E, Collette, L, Oprea-Lager, D E, Kunz, W G, Bidaut, L, Verhoeff, J J C, Caramella, C, Lopci, E, Tombal, B, de Geus-Oei, L-F, Fournier, L, Smits, M & deSouza, N M 2020, ' Impact of the COVID-19 crisis on imaging in oncological trials ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 9, pp. 2054-2058 . https://doi.org/10.1007/s00259-020-04910-y
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, no. 9, p. 2054-2058 (2020)
European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, no. 9, p. 2054-2058 (2020)
European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 47(9), 2054-2058. Springer-Verlag
The unprecedented demand for hospital services during the SARS-CoV-2 (COVID-19) pandemic has dramatically reduced the capability for dealing with non-acute health needs, including cancer care [1, 2]. To alleviate burden on health care systems, includ